Murj scoops $8.5M to enable boom in devices and data

A screen from Murj's platform (Murj)

Murj thinks it has spotted a bottleneck in the adoption of implantable cardiac medical devices. With each device and the data it generates adding to the workload of cardiac clinics, the startup sees the burden on clinics becoming too much. Now, Murj has raised $8.5 million to advance its answer to the problem.  

Innovation in the cardiac implant sector is increasing the device options available to patients and the quantity of data they generate. At the same time, demographic and lifestyle changes are increasing the number of patients in the U.S. who need cardiac interventions. The result is that cardiac clinics are handling more patients, devices and data than before.

That is the rationale behind Murj, which has developed a cloud-based workflow intended to lighten the load on clinics. The platform pulls in data on patients and their devices to make it easier for clinics to monitor and process them.

Whitepaper

Overcoming Risk in Oncology Drug Development

Oncology drug development is full of potential obstacles and risks, and you must carefully plan each step. Download this whitepaper for tips on finding the fast track. Premier Research. Built for Biotech.

Murj exited from stealth mode with a $4.5 million series A round about one year ago, before going on to unveil its platform the following month. Having picked up customers including Alaska Heart & Vascular Institute, Murj has now gone back to investors for money to support the next stage of its development. 

New backer Longitude Capital stepped up and led the round with the support of True Ventures—the chief contributor to the series A—and other existing investors. Murj will use the money to step up its commercialization of the platform.

Suggested Articles

The FDA approved the first spinal tether to correct the most common form of scoliosis—a ropelike implant that pulls the vertebrae into shape.

Agilent launched a new analyzer for research that observes cell behavior in real time while also collecting biosensor information.

Five years after Congress passed a law to reduce unnecessary MRIs and CT scans, federal officials have yet to implement it.